Drug Trial Radar · NCT05430854
Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study
Last checked: Nov 19, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
155
Actual
Start
Jun 1, 2022
Primary completion
Oct 31, 2023
Study completion Oct 31, 2023
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Jun 24, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 72 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2, Open-Label Extension study to evaluate the long-term safety and tolerability of daxdilimab in participants with Systemic Lupus Erythematosus completing the treatment period of the RECAST SLE clinical study.
Conditions
- Systemic Lupus Erythematosus
Interventions
DaxdilimabBiological
Daxdilimab will be administered subcutaneously as two injections for each dose.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Who Experienced Treatment-emergent Adverse Events (TEAEs)Time frame: Up to approximately 56 weeks
- Number of Participants Who Experienced Serious Adverse Events (SAEs)Time frame: Up to approximately 56 weeks
- Number of Participants Who Experienced AEs of Special Interest (AESI)Time frame: Up to approximately 56 weeks
Locations
52 sites in 9 countries. Site status is shown where the registry gives one.
Inland Rheumatology Clinical Trials Incorporated
Upland, California
Clinical Research of West Florida Inc - Clearwater
Clearwater, Florida
Millennium Research
Ormond Beach, Florida
IRIS Research and Development LLC
Plantation, Florida
Clinical Research of West Florida Inc - Tampa
Tampa, Florida
Emory University School of Medicine
Atlanta, Georgia
Bluegrass Community Research Inc
Lexington, Kentucky
NYU Langone Ambulatory Care Brooklyn Heights
Brooklyn, New York
DJL Clinical Research
Charlotte, North Carolina
Paramount Medical Research and Consulting LLC
Middleburg Heights, Ohio
Precision Comprehensive Clinical Research Solutions
Colleyville, Texas
Metroplex Clinical Research Center
Dallas, Texas
Southwest Rheumatology Research, LLC
Mesquite, Texas
Spectrum Medical, Inc
Danville, Virginia
Consultorios Médicos Dr. Doreski
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Clínica Adventista Belgrano
Estomba, Buenos Aires, Argentina
Framingham Centro Médico
La Plata, Buenos Aires, Argentina
Instituto CER S.A
Quilmes, Buenos Aires, Argentina
Instituto de Investigaciones Clinicas Quilmes SRL
Quilmes, Buenos Aires, Argentina
Centro Medico Privado de Reumatologia
San Miguel de Tucumán, Tucumán Province, Argentina
Consultorio de Investigaciones Reumatologicas
San Miguel de Tucumán, Tucumán Province, Argentina
Athens General Hospital 'G Gennimatas
Athens, Greece
Laiko General Hospital of Athens
Athens, Greece
University General Hospital of Larissa
Larissa, Greece
Kianous Stavros
Thessaloniki, Greece
Krishna Institute of Medical Sciences
Secunderabad, Andhra Pradesh, India
AES - AS - Panchshil Hospital - Ahmedabad
Ahmedabad, Gujarat, India
AES - AS - Unity Trauma Center and ICU - Unity Hospital - Surat
Surat, Gujarat, India
AES - AS - Sushruta Multispeciality Hospital & Research Center Pvt Ltd - Hubli
Hubli, Karnataka, India
Jasleen Hospital
Nagpur, Maharashtra, India
Clinica de Investigacion en Reumatologia y Obesidad
Guadalajara, Mexico
Centro de Estudios de Investigacion Basica Y Clinica SC
Jalisco, Mexico
Consultorio de Reumatologia
Mexico City, Mexico
Centro de Investigación en Artritis y Osteoporosis
Mexicali, Estado de Baja California, Mexico
Morales Vargas Centro de Investigacion SC
León, Guanajuato, Mexico
Bioclinica - Centro Integral En Reumatologia Sociedad Anónima de Capital Variable
Guadalajara, Jalisco, Mexico
Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.
Zapopan, Jalisco, Mexico
Centro de Investigación y Tratamiento Reumatológico S.C
San Miguel, Mexico City, Mexico
Centro Peninsular de Investigacion S.C.P
Mérida, Yucatán, Mexico
Nasz Lekarz Osrodek Badan Klinicznych
Bydgoszcz, Poland
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.